Close Menu

NEW YORK – GenMark Diagnostics said after the close of the market on Thursday that its fourth quarter revenues rose 84 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, 2020, the Carlsbad, California-based company reported revenues of $50.1 million compared to $27.2 million in Q4 2019 and beating analysts' consensus estimate of $47.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.